Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Author:
Affiliation:
1. Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA; and
2. Departments of Medicine,
3. Pediatrics, and
4. Biostatistics, University of Washington School of Medicine, Seattle, WA
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/117/11/3214/1335797/zh801111003214.pdf
Reference41 articles.
1. Graft-versus-host disease.;Sullivan,1999
2. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.;Glucksberg;Transplantation,1974
3. 1994 Consensus Conference on Acute GVHD Grading.;Przepiorka;Bone Marrow Transplant,1995
4. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.;Rowlings;Br J Haematol,1997
5. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.;Shulman;Am J Med,1980
Cited by 550 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Epidemiology and risk factors for the development of cicatrizing conjunctivitis in chronic ocular graft-versus-host disease;The Ocular Surface;2024-10
2. Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD;Cells;2024-09-11
3. Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus;Transplantation Proceedings;2024-09
4. Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients;Transplantation and Cellular Therapy;2024-09
5. Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential;Frontiers in Immunology;2024-08-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3